OCTRU Senior Health Economist
I joined the Oxford Clinical Trials Unit, as a senior health economist in January 2016. My main responsibility is to provide health economics support to the research activities in the Nuffield Department of Rheumatology and Musculoskeletal Sciences (NDORMS). My current work includes the economic evaluation of distal radial fractures treated by plaster cast versus surgical K‐wire (DRAFTT2), progressive exercise vs best practice advice and corticosteroid injection vs no corticosteroid injection for the treatment of rotator cuff disorder (GRASP), standard wound management versus negative pressure wound therapy for major trauma to the lower limb (WHIST).
Prior to my current position, I have worked as a research fellow at the clinical trials unit, Warwick Medical School (WMS), University of Warwick. I have also acted health economic advisor for the National Institute of Health Research (NIHR) Warwick hub of the West Midlands Research Design Services (RDS). Other appointments include research fellow at Brunel University, lecturer at Cass Business School and teaching fellow at Royal Holloway University.
My work is published in numerous international scientific journals and also presented in prestigious conferences in my field. I provide peer review for NIHR grant applications and for the Health Economics, British Medical Journal, Advances in Therapy, Chronic Respiratory Disease. I am a member of the Editorial board of the Athens Journal of Health and the Bone and Joint Journal.
My research interests relate to applied economic evaluation of health care interventions alongside clinical trials and beyond.
I am a member of the UK Health Economists’ Study group (HESG), the International Health Economics Association (IhEA), Royal Statistical Society (RSS), International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Athens Institute for Education and Research (ATINER) and John Snow Society (Royal Institute of Public Health).
Young Investigators Award. Cost-utility analysis of a self-management programme of activity, coping and education for COPD. European Respiratory Society. September 2015
Study protocol: A multi-centre, double blind, randomised,
placebo-controlled, parallel group, phase II trial (RIDD) to
determine the efficacy of intra-nodular injection of anti-TNF to
control disease progression in early Dupuytren’s disease, with
an embedded dose response study
Nanchahal J. et al, (2017), Wellcome Open Research
Labour induction near term for women aged 35 or over: an economic evaluation.
Walker KF. et al, (2017), BJOG, 124, 929 - 934
Becoming confident about confidence intervals.
Perry DC. et al, (2017), Bone Joint J, 99-B, 563 - 565
Timely Digital Patient-Clinician Communication in Specialist
Clinical Services for Young People:A Mixed-Methods Study (The
Griffiths F. et al, (2017), Journal of Medical Internet Research, 19
Efficacy versus effectiveness in clinical trials
Costa ML. et al, (2017), BONE & JOINT JOURNAL, 99B, 419 - 420